Lumateperone — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09 (month) in 2mo
ESTIMATED |
READOUT
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Ma
Phase 3 · Major Depressive Disorder |
Intra-Cellular Therapies, Inc. | Lumateperone |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|